Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
The American Journal of Gastroenterology|June 4, 2009
Most doctors win: what to do if sued for medical malpracticeAndrew D Feld, Richard E MosesThe American Journal of Gastroenterology|January 11, 2008
Legal risks of clinical practice guidelinesRichard E Moses, Andrew D FeldThe American Journal of Gastroenterology|July 2, 2014
Social media in the health-care setting: benefits but also a minefield of compliance and other legal issuesRichard E Moses, Libra G McNeese, Lauren D Feld, et al.Current Medical Research and Opinion|January 8, 2026
Prevalence of bowel urgency and its association with quality of life and disease severity among patients with inflammatory bowel disease: results from the real-world measuring urgency symptoms in inflammatory bowel disease collaboration (MUSIC) online studyMillie D Long, Theresa Marie Hunter, Angela Dobes, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 4, 2023
Validation of the bowel urgency numeric rating scale in patients with Crohn's disease: results from a mixed methods studyMarla C Dubinsky, Laure Delbecque, Theresa Hunter, et al.Gastro Hep Advances|October 27, 2025
Bowel Urgency Severity Among Patients with Crohn's Disease or Ulcerative Colitis on Advanced Therapies: Real-World Data Using Study of a Prospective Adult Research Cohort with Inflammatory Bowel DiseaseJames D Lewis, Wai Man Maria Chan, Richard E Moses, et al.Crohn'S & Colitis 360|July 1, 2025
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative ColitisRemo Panaccione, Faye Chan-Diehl, Simin Baygani, et al.Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.Journal of Patient-Reported Outcomes|July 1, 2025
Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumabDavid B Clemow, Marla C Dubinsky, Simin K Baygani, et al.Inflammatory Bowel Diseases|January 25, 2024
Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT TrialsGeert D'Haens, Peter D R Higgins, Laurent Peyrin-Biroulet, et al.Pageof 2